ClinicalTrials.gg
RecruitingNCT07324343Updated Nov 3, 2026

Which Patient Group Shows Greater Improvement With Patient Education Alone in Rotator Cuff-Related Shoulder Pain? - A Cohort Study

An interventional study of Questionnaire Validation and Patient Education in Shoulder Pain Syndrome, Subacromial Pain Syndrome and Rotator Cuff Related Shoulder Pain, sponsored by Istanbul University - Cerrahpasa. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-03.

Primary conditionShoulder PainRegistry: PainReclassifiedWhy we changed it
Registry
Pain — the first condition term the registry derived for this study.
ClinicalTrials.gg
Shoulder Pain
Why
  1. The study's listed conditions name Shoulder Pain, a narrower term within Pain.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Istanbul University - Cerrahpasa · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Sep 2025; still recruiting 1 year 2 months later.
Updated Nov 3, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
116
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 15 studies in Shoulder Pain by Istanbul University - Cerrahpasa — 3 open to participants now, 3 under way, none of them phase 3. Shoulder Pain · Istanbul University - Cerrahpasa.

Planned enrollment
2nd of 13
116 · median 48
Started
2025
with 1 other
No phase
13 of 15
2 open now
Registered
15th of 15
by date

Among the 15 studies in Shoulder Pain by Istanbul University - Cerrahpasa, this one is the 2nd largest by planned enrollment of the 13 interventional ones that give a count, is one of 2 that started in 2025, is one of 13 with no phase, and was the 15th registered.

Shoulder Pain

738 studies on the registry are indexed under Shoulder Pain; 168 are open to participants now.

Browse Shoulder Pain studies →

Open to participants now

3 of the 15 studies in Shoulder Pain by Istanbul University - Cerrahpasa are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 90 Shoulder Pain studies recruiting now, 25 (28%) set no upper age limit and 55 (61%) stop at 75 or younger; 3 take children under 18; 15 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Shoulder Pain by Istanbul University - Cerrahpasa, or all of them as a file.
02

Study summary

The primary aim of this study is to determine the clinical effectiveness of patient education alone in individuals with rotator cuff-related shoulder pain and to identify which patient subgroups benefit more from this approach. In addition, the translation and cultural adaptation of the "Patient Knowledge Questionnaire (PKQ-RCRSP)" into Turkish will be carried out to measure the level of patient knowledge regarding patient education.

Read the detailed description

Individuals who present with shoulder pain to the Orthopedics and Traumatology Department, Shoulder-Elbow Surgery Outpatient Clinic of Göztepe Prof. Dr. Süleyman Yalçın City Hospital and who volunteer to participate will be included in our study. Before beginning the study, the purpose of the study will be explained to the participants, and all information regarding the study will be provided both verbally and in writing. Informed consent will be obtained from participants, confirming that they voluntarily agree to take part in the study. A total of 116 participants will be included in the study, and the PKQ-RCRSP questionnaire will be administered at baseline and after one week. Following the validation process, participants will receive two face-to-face patient education sessions. After the first patient education session, pain will be assessed at the 4th, 12th, and 24th week follow-ups using the Numerical Pain Rating Scale (NPRS); functional limitation will be assessed using the Shoulder Pain and Disability Index (SPADI); clinical improvement using the Global Rating of Change Scale (GRC); illness perception using the Brief Illness Perception Questionnaire (B-IPQ); patient knowledge level using the PKQ-RCRSP; health literacy using the European Health Literacy Survey-Short Form (HLS-EU-Q6); and physical activity level using the International Physical Activity Questionnaire (IPAQ).

03

Conditions studied

  • Shoulder Pain Syndrome
  • Subacromial Pain Syndrome
  • Rotator Cuff Related Shoulder Pain
  • Patient Education

Browse trials for

Keywords

  • patient education
  • Rotator Cuff Related Shoulder Pain
04

In context

Shoulder Pain Reclassified

738 studies on the registry are indexed under Shoulder Pain; 168 are open to participants now.

This study's planned enrollment of 116 is above the median of 60 across 590 interventional studies indexed under Shoulder Pain.

Browse Shoulder Pain studies →

Lead sponsor

Istanbul University - Cerrahpasa is the lead sponsor of 702 studies on the registry; 212 are open to participants now.

Compared within Shoulder Pain, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Pain. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals aged 18-65 years
  • Shoulder pain persisting for at least 4 weeks
  • Diagnosed by an orthopedic physician with impingement, subacromial bursitis, rotator cuff (RC) tendinopathy, or partial tear
  • Activity-related pain ≥3 on the NPRS
  • Cognitively able to understand the education and provide written

Exclusion criteria

Exclusion Criteria:

  • History of shoulder surgery
  • Diagnosis of frozen shoulder, full-thickness or massive rotator cuff (RC) tear, or instability
  • Presence of neurological or psychiatric conditions that prevent exercise
  • History of physical therapy-rehabilitation or injection treatment within the past 6 months
  • Pain persisting for more than 12 months
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
116 participants (estimated)

Study arms

  • Experimental
    Patient Education

    Participants in this study will receive structured patient education sessions for rotator cuff-related shoulder pain.

    Behavioral: Questionnaire Validation · Behavioral: Patient Education

Interventions

  • BehavioralQuestionnaire Validation

    During the Turkish adaptation of the PKQ-RCRSP questionnaire, written permission was obtained from the original developer. At least two experts independently translated the questionnaire into Turkish, and a single reconciled version was created. This version was back-translated by an independent translator to ensure semantic and conceptual equivalence. Revisions were made following expert panel review and pilot testing. For validation, the PKQ-RCRSP will be administered to participants at baseline (V0). One week later (V1), the questionnaire will be repeated, and participants will be asked if their shoulder problem or knowledge has significantly changed in the past week. Those answering "Yes," who do not return, or who receive any intervention will be excluded from the test-retest analysis. Results from participants answering "No" will complete the test-retest analysis, and all participants' data will be included in other validity analyses. This concludes the validation phase.

  • BehavioralPatient Education

    Participants in this arm will receive structured patient education sessions for rotator cuff-related shoulder pain. The program consists of two 30-minute face-to-face sessions delivered by a physiotherapist with at least 5 years of experience in orthopedic rehabilitation. Educational topics include disease information, symptom management, treatment options, reducing fear of movement, exercise promotion, pain and stress management, physical activity recommendations, nutrition advice, and lifestyle-specific guidance. Informational brochures will be provided after the first session. The second session, delivered two weeks later, focuses on reviewing progress and enhancing motivation; no new information will be provided.

07

What researchers measure

Primary outcomes

  1. Numerical Pain Rating Scale (NPRS)

    Pain intensity assessed using the Numerical Pain Rating Scale (NPRS).

    Time frame: İmmediately before the first education session, and at 4 weeks, 12 weeks, and 24 weeks after the start of the education program.

Secondary outcomes

  1. Patient Knowledge Questionnaire (PKQ-RCRSP)

    Patient knowledge regarding rotator cuff-related shoulder pain assessed

    Time frame: Baseline, immediately before the first education session, and at 4 weeks, 12 weeks, and 24 weeks after the start of the education program.

Other outcomes

  1. Shoulder Pain and Disability Index (SPADI)

    Shoulder pain and functional disability assessed using the Shoulder Pain and Disability Index (SPADI).

    Time frame: Baseline, and at 4 weeks, 12 weeks, and 24 weeks after the start of the education program.

  2. Sociodemographic Characteristics

    Sociodemographic characteristics including age, sex, education level, occupation, and other relevant demographic variables collected using a Sociodemographic Assessment Form.

    Time frame: Baseline.

  3. Patient-Reported Global Change Assessed by the Global Rating of Change Scale (GRC)

    Patient-perceived overall change in condition assessed using the Global Rating of Change Scale (GRC).

    Time frame: 4 weeks, 12 weeks, and 24 weeks after the start of the education program

  4. Illness Perceptions Assessed by the Brief Illness Perception Questionnaire (B-IPQ)

    Patient perceptions of illness assessed using the Brief Illness Perception Questionnaire (B-IPQ).

    Time frame: Baseline and at 4 weeks, 12 weeks, and 24 weeks after the start of the education program.

  5. European Health Literacy Survey - Short Form (HLS-EU-Q6)

    Health literacy level assessed using the European Health Literacy Survey - Short Form (HLS-EU-Q6).

    Time frame: Baseline, and at 4 weeks, 12 weeks, and 24 weeks after the start of the education program.

  6. European Health Literacy Survey - Short Form (HLS-EU-Q6).

    Health literacy level assessed using the European Health Literacy Survey - Short Form (HLS-EU-

    Time frame: Baseline and at 12 weeks and 24 weeks after the start of the education program.

  7. International Physical Activity Questionnaire - Short Form (IPAQ-SF / UFAA-KF)

    Physical activity level assessed using the International Physical Activity Questionnaire - Short Form (IPAQ-SF).

    Time frame: Baseline and at 12 weeks and 24 weeks after the start of the education program.

08

Study locations

1 of 1 sites recruiting
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for Sep 2027, 24 months after the start.

Of 351 non-industry interventional studies with no phase under Shoulder Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 24 months is above that.

Counting every sponsor, half of 356 studies reached it within 11 months; a quarter within 4 and three quarters within 27.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 3, 2026: primary completion Sep 2026 → Sep 2027 and completion Dec 2026 → Sep 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 27, 2025
First posted
Jan 7, 2026
StartActual
Sep 1, 2025
Primary completionEst.
Sep 1, 2027was Sep 2026
CompletionEst.
Sep 1, 2027was Dec 2026
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Sep 1, 2026→Sep 1, 2027
Nov 3, 2026
Study completion
Dec 1, 2026→Sep 1, 2027
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    Primary completion Sep 1, 2026→Sep 1, 2027
    Study completion Dec 1, 2026→Sep 1, 2027

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT07324343
Responsible party
Merve Koyuncu Cenikli (Research Asistant, PT, Istanbul University - Cerrahpasa) — Principal investigator
First posted
Jan 7, 2026
Start date
Sep 1, 2025
Primary completion
Sep 1, 2027 (estimated)
Completion
Sep 1, 2027 (estimated)
Last update
Nov 3, 2026

Study contacts

Merve KOYUNCU CENİKLİ Research asistant, MSc
Contact
merve.cenikli@iuc.edu.tr
+90(0212) 414 15 00

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion